Kovack Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
2,906
+5
| +0.2% | +$349 | 0.02% | 560 |
|
|
2025
Q1 | $213K | Buy |
+2,901
| New | +$213K | 0.02% | 520 |
|
|
2024
Q4 | – | Sell |
-2,871
| Closed | -$224K | – | 614 |
|
|
2024
Q3 | $224K | Sell |
2,871
-189
| -6% | -$14.7K | 0.02% | 517 |
|
|
2024
Q2 | $239K | Buy |
3,060
+85
| +3% | +$6.63K | 0.03% | 477 |
|
|
2024
Q1 | $202K | Buy |
+2,975
| New | +$202K | 0.02% | 435 |
|
|
2023
Q3 | – | Sell |
-2,994
| Closed | -$214K | – | 553 |
|
|
2023
Q2 | $214K | Buy |
2,994
+41
| +1% | +$2.93K | 0.03% | 497 |
|
|
2023
Q1 | $205K | Sell |
2,953
-43
| -1% | -$2.99K | 0.03% | 512 |
|
|
2022
Q4 | $203K | Buy |
+2,996
| New | +$203K | 0.03% | 515 |
|
|
2022
Q3 | – | Sell |
-3,332
| Closed | -$220K | – | 556 |
|
|
2022
Q2 | $220K | Sell |
3,332
-1,336
| -29% | -$88.2K | 0.03% | 542 |
|
|
2022
Q1 | $309K | Buy |
4,668
+763
| +20% | +$50.5K | 0.03% | 519 |
|
|
2021
Q4 | $227K | Sell |
3,905
-885
| -18% | -$51.4K | 0.02% | 613 |
|
|
2021
Q3 | $288K | Buy |
4,790
+397
| +9% | +$23.9K | 0.03% | 544 |
|
|
2021
Q2 | $263K | Buy |
4,393
+100
| +2% | +$5.99K | 0.03% | 557 |
|
|
2021
Q1 | $213K | Buy |
+4,293
| New | +$213K | 0.03% | 564 |
|